H2 receptor antagonists are drugs that inhibit histamine action in the stomach, reducing acid production.

CGRP antagonists are drugs that block the CGRP receptor, used in preventing migraines.

D2 receptor agonists are drugs that activate the D2 subtype of dopamine receptors, used in treating conditions like Parkinson’s disease and hyperprolactinemia.

NK1 antagonists are drugs that block the neurokinin-1 receptor, aiding in the treatment of nausea, vomiting, and psychiatric disorders.

Melatonin receptor agonists are drugs that activate melatonin receptors, aiding in the treatment of sleep disorders.

TLR7 agonists are compounds that activate the Toll-like receptor 7, stimulating the immune system against viral infections.

Syk inhibitors are drugs that target and inhibit the spleen tyrosine kinase enzyme, crucial in immune cell signaling.

NOS inhibitors are drugs that inhibit nitric oxide synthase, an enzyme crucial in various physiological processes.

VMAT2 inhibitors are drugs that target and inhibit the vesicular monoamine transporter 2 protein, crucial in neurotransmitter regulation.

VEGF inhibitors are drugs that block the activity of vascular endothelial growth factor, crucial in angiogenesis.

The development of TNF inhibitors has been a significant advancement in the treatment of autoimmune diseases.

Telomerase inhibitors are drugs that target the enzyme telomerase, crucial in maintaining DNA integrity and stability.